BOSTON, Sept. 30, 2024 -- Aktis Oncology, a clinical-stage biotechnology company pioneering the discovery and development of novel targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today...
Athersys begins Phase I trial for ATHX-105 for treatment of obesity
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.